These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19250114)

  • 1. Analysis of 57,148 transmissions by remote monitoring of implantable cardioverter defibrillators.
    Theuns DA; Rivero-Ayerza M; Knops P; Res JC; Jordaens L
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S63-5. PubMed ID: 19250114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical and practical aspects of remote monitoring of implantable cardioverter-defibrillator patients in Poland - preliminary results.
    Przybylski A; Zakrzewska-Koperska J; Maciag A; Derejko P; Orczykowski M; Szumowski L; Walczak F
    Kardiol Pol; 2009 May; 67(5):505-11. PubMed ID: 19521935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of cancelled shock therapy and relationship to shock delivery in recipients of implantable cardioverter-defibrillators assessed by remote monitoring.
    Varma N; Johnson MA
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S42-6. PubMed ID: 19250110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database.
    Lazarus A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S2-S12. PubMed ID: 17302706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automatic home monitoring of implantable cardioverter defibrillators.
    Nielsen JC; Kottkamp H; Zabel M; Aliot E; Kreutzer U; Bauer A; Schuchert A; Neuser H; Schumacher B; Schmidinger H; Stix G; Clémenty J; Danilovic D; Hindricks G
    Europace; 2008 Jun; 10(6):729-35. PubMed ID: 18434298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator.
    Heidbüchel H; Lioen P; Foulon S; Huybrechts W; Ector J; Willems R; Ector H
    Europace; 2008 Mar; 10(3):351-7. PubMed ID: 18245771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study.
    Varma N
    Am Heart J; 2007 Dec; 154(6):1029-34. PubMed ID: 18035071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.
    Landolina M; Perego GB; Lunati M; Curnis A; Guenzati G; Vicentini A; Parati G; Borghi G; Zanaboni P; Valsecchi S; Marzegalli M
    Circulation; 2012 Jun; 125(24):2985-92. PubMed ID: 22626743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population.
    Sacher F; Probst V; Bessouet M; Wright M; Maluski A; Abbey S; Bordachar P; Deplagne A; Ploux S; Lande G; Jaïs P; Hocini M; Haïssaguerre M; Le Marec H; Clémenty J
    Europace; 2009 Apr; 11(4):489-94. PubMed ID: 19218576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Work burden with remote monitoring of implantable cardioverter defibrillator: is it time for reimbursement policies?
    Papavasileiou LP; Forleo GB; Panattoni G; Schirripa V; Minni V; Magliano G; Bellos K; Santini L; Romeo F
    J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):114-9. PubMed ID: 22644407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of programmed number of intervals to detect ventricular fibrillation on implantable cardioverter-defibrillator aborted and unnecessary shocks.
    Gunderson BD; Abeyratne AI; Olson WH; Swerdlow CD
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):157-65. PubMed ID: 17338710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
    Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
    Albert CM; Rosenthal L; Calkins H; Steinberg JS; Ruskin JN; Wang P; Muller JE; Mittleman MA;
    J Am Coll Cardiol; 2007 Dec; 50(23):2233-40. PubMed ID: 18061071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.
    Wilkoff BL; Ousdigian KT; Sterns LD; Wang ZJ; Wilson RD; Morgan JM;
    J Am Coll Cardiol; 2006 Jul; 48(2):330-9. PubMed ID: 16843184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian, daily, and seasonal distributions of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
    Anand K; Aryana A; Cloutier D; Hee T; Esterbrooks D; Mooss AN; Mohiuddin SM
    Am J Cardiol; 2007 Oct; 100(7):1134-8. PubMed ID: 17884377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-tailored implantable cardioverter defibrillator testing using the upper limit of vulnerability: the TULIP protocol.
    Lemke B; Lawo T; Zarse M; Lubinski A; Kreutzer U; Mueller J; Schuchert A; Mitzenheim S; Danilovic D; Deneke T;
    Europace; 2008 Aug; 10(8):907-13. PubMed ID: 18515789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial.
    Al-Khatib SM; Piccini JP; Knight D; Stewart M; Clapp-Channing N; Sanders GD
    J Cardiovasc Electrophysiol; 2010 May; 21(5):545-50. PubMed ID: 20021522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillator shocks increase T-wave alternans.
    Lampert R; Soufer R; McPherson CA; Batsford WP; Tirado S; Earley C; Goldberg A; Shusterman V
    J Cardiovasc Electrophysiol; 2007 May; 18(5):512-7. PubMed ID: 17428273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.